8-K - Edesa Biotech, Inc. (0001540159) (Filer)
Published . Updated .
Key takeaways
- 8-K - Edesa Biotech filed an 8-K with the SEC on Nov 17 (a notice of a material company event).
- Exposed: EDSA
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest and never sell or share it. See our privacy policy.
8-K - Edesa Biotech filed an 8-K with the SEC on Nov 17 (a notice of a material company event).
Directly affected
- EDSA Edesa Biotech-46.1% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “biotech” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “biotech” (pharma and health) in this story.
- LLY Eli Lilly and+25.1% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.
- JNJ Johnson & Johnson+12.1% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.
- PFE Pfizer+5.2% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.
- MRK Merck+3.5% 30d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| EDSA | +5.57% | +10.34% | base | after close | after close | after close | after close |
| XLV | +0.52% | -0.04% | base | after close | after close | after close | after close |
| XBI | +6.26% | +3.61% | base | +0.86% | after close | after close | after close |
| LLY | -0.12% | -0.28% | base | -0.81% | after close | after close | after close |
| JNJ | -0.65% | +0.33% | base | -1.55% | after close | after close | after close |
| PFE | +1.66% | -0.17% | base | -1.45% | after close | after close | after close |
| MRK | +2.39% | +1.67% | base | -0.82% | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-17 AccNo: 0001171843-26-007511 Size: 189 KB Item 8.01: Other Events
Source: sec-edgar
Edesa Biotech (EDSA)
Across 3 earlier stories, Edesa Biotech (EDSA) the next day averaged -4.12%. The largest gain was 0.00% and the largest drop was -9.13%, from 3 prices.
| Company | When | Average | Largest gain | Largest drop | Prices |
|---|---|---|---|---|---|
| Edesa Biotech (EDSA) | the next day | -4.12% | 0.00% | -9.13% | 3 |
| Edesa Biotech (EDSA) | three days later | +3.58% | +14.26% | -5.02% | 3 |
Edesa Biotech (EDSA) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| Edesa Biotech (EDSA) | three days earlier | +10.34% | final price |
| Edesa Biotech (EDSA) | five days earlier | +5.57% | final price |
| JNJ | that day | -1.55% | still updating |
| JNJ | three days earlier | +0.33% | final price |
| JNJ | five days earlier | -0.65% | final price |
| LLY | that day | -0.81% | still updating |
| LLY | three days earlier | -0.28% | final price |
| LLY | five days earlier | -0.12% | final price |
| MRK | that day | -0.82% | still updating |
| MRK | three days earlier | +1.67% | final price |
| MRK | five days earlier | +2.39% | final price |
| PFE | that day | -1.45% | still updating |
| PFE | three days earlier | -0.17% | final price |
| PFE | five days earlier | +1.66% | final price |
| XBI | that day | +0.86% | still updating |
| XBI | three days earlier | +3.61% | final price |
| XBI | five days earlier | +6.26% | final price |
| XLV | three days earlier | -0.04% | final price |
| XLV | five days earlier | +0.52% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. David J. Taylor sold Eli Lilly (LLY), worth $1,001 - $15,000 on 3 Nov 2026. That is 14 days before publication. Filed 12 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 28 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 74 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 41 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 48 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 74 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 88 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 90 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - Edesa Biotech, Inc. (0001540159) (Filer)”
Companies carried with this story
- EDSA Edesa Biotech
For “8-K - Edesa Biotech, Inc. (0001540159) (Filer),” Edesa Biotech (EDSA) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> EDSA
How “8-K - Edesa Biotech, Inc. (0001540159) (Filer)” reaches Edesa Biotech (EDSA)
On 17 Nov 2026, “8-K - Edesa Biotech, Inc. (0001540159) (Filer)” is the story that connects Edesa Biotech (EDSA) to this story.
For Edesa Biotech (EDSA), the reason on file says SEC 8-K filing -> direct issuer disclosure -> EDSA
Dates and price levels for Edesa Biotech (EDSA)
EDSA traded between 1.86 and 3.90 across 20 sessions. The latest close on file is 2.08.
What the saved facts support for Edesa Biotech (EDSA)
14 out of 100Price not final
“8-K - Edesa Biotech, Inc. (0001540159) (Filer)” scores 14 out of 100. The score uses 1 source, and 1 linked company. The price is not final yet.